Hosted on MSN10mon
Eli Lilly warns 2 of its insulin products may be out of stockPatients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro ...
Hosted on MSN10mon
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaosEli Lilly has not said why it is seeing this shortage ... Patients will have a harder time getting their Humalog and Insulin Lispro Injections at wholesalers and pharmacies through the beginning ...
Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...
After years of preparation, Eli Lilly is on the brink of launching a ... including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price lowered by equities researchers at Citigroup from $1,250.00 to $1,190.00 in a research note issued to investors on ...
Eli Lilly and Company (NYSE:LLY – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback